We are live on ! Find out more
SCM

Sterling Capital Management Portfolio holdings

AUM $5.9B
1-Year Est. Return 29.63%
This Fund
S&P 500
This Quarter Est. Return
+17.46%
1 Year Est. Return
+29.63%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$5.9B
AUM Growth
+$620M
Cap. Flow
-$8.35M
Cap. Flow %
-0.14%
Top 10 Hldgs %
23.55%
Holding
3,465
New
250
Increased
687
Reduced
2,249
Closed
176

Top Sells

Rank Stock Value
1
MRVL icon
Marvell Technology
MRVL
+$47.2M
2
MSFT icon
Microsoft
MSFT
+$38.2M
3
AAPL icon
Apple
AAPL
+$37M
4
AMZN icon
Amazon
AMZN
+$35.5M
5
CTRA
Coterra Energy
CTRA
+$34.4M

Sector Composition

Rank Sector Weight
1 Miscellaneous 21.44%
2 Technology 20.51%
3 Financials 13.46%
4 Industrials 10.73%
5 Healthcare 7.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AMCX icon
2401
AMC Global Media
AMCX
$498M
$6.38K ﹤0.01%
639
-381
-37% -$3.38K
VNDA icon
2402
Vanda Pharmaceuticals
VNDA
$322M
$6.38K ﹤0.01%
1,042
-804
-44% -$5.25K
HLIT icon
2403
Harmonic Inc
HLIT
$1.3B
$6.37K ﹤0.01%
390
-2,552
-87% -$32.6K
NN icon
2404
NextNav
NN
$2.57B
$6.35K ﹤0.01%
356
-260
-42% -$5.03K
WSBF icon
2405
Waterstone Financial
WSBF
$381M
$6.34K ﹤0.01%
306
-197
-39% -$3.67K
ODC icon
2406
Oil-Dri
ODC
$1.25B
$6.34K ﹤0.01%
62
-57
-48% -$4.56K
STOK icon
2407
Stoke Therapeutics
STOK
$1.94B
$6.32K ﹤0.01%
193
-125
-39% -$4.01K
CZFS icon
2408
Citizens Financial Services
CZFS
$396M
$6.3K ﹤0.01%
87
-53
-38% -$3.5K
AQST icon
2409
Aquestive Therapeutics
AQST
$654M
$6.29K ﹤0.01%
1,513
-947
-38% -$3.98K
GLUE icon
2410
Monte Rosa Therapeutics
GLUE
$1.22B
$6.29K ﹤0.01%
260
-1,745
-87% -$33K
IDT icon
2411
IDT Corp
IDT
$1.7B
$6.28K ﹤0.01%
108
-96
-47% -$5.08K
PPTA
2412
Perpetua Resources
PPTA
$3.1B
$6.27K ﹤0.01%
302
-260
-46% -$7.05K
RCKT icon
2413
Rocket Pharmaceuticals
RCKT
$407M
$6.24K ﹤0.01%
1,823
-639
-26% -$2.13K
BFLY icon
2414
Butterfly Network
BFLY
$2B
$6.22K ﹤0.01%
739
-533
-42% -$2.76K
WTI icon
2415
W&T Offshore
WTI
$598M
$6.22K ﹤0.01%
1,974
-1,312
-40% -$4.87K
LODE icon
2416
Comstock
LODE
$234M
$6.19K ﹤0.01%
+1,487
New +$5.41K
AVBH
2417
Avidbank Holdings
AVBH
$348M
$6.18K ﹤0.01%
187
+100
+115% +$3.05K
GNE icon
2418
Genie Energy
GNE
$411M
$6.16K ﹤0.01%
426
-214
-33% -$2.99K
RM icon
2419
Regional Management Corp
RM
$305M
$6.14K ﹤0.01%
149
-117
-44% -$4.29K
DRAM
2420
Roundhill Memory ETF
DRAM
$28.7B
$6.13K ﹤0.01%
+83
New +$4.32K
FLNC icon
2421
Fluence Energy
FLNC
$1.58B
$6.1K ﹤0.01%
307
-518
-63% -$9.63K
MBI icon
2422
MBIA
MBI
$235M
$6.1K ﹤0.01%
936
-577
-38% -$3.48K
IPSC icon
2423
Century Therapeutics
IPSC
$375M
$6.09K ﹤0.01%
+2,484
New +$5.67K
EVTC icon
2424
Evertec
EVTC
$1.73B
$6.08K ﹤0.01%
219
-199
-48% -$5.29K
YSWY
2425
Yesway Inc
YSWY
$755M
$6.07K ﹤0.01%
+299
New +$6.94K

Similar funds

Sterling Capital Management's Q2 2026 Portfolio in Review

As of Q2 2026, Sterling Capital Management held 3,465 positions worth $5.9B, up 12% from $5.28B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Sterling Capital Management's Q2 2026 filing shows 250 new, 687 increased, 2,249 reduced and 176 closed positions. Its largest new stake was Coca-Cola Europacific Partners: 217,119 shares worth $21.7M. The largest sale was Marvell Technology, an estimated $47.2M.

By sector, the portfolio is most concentrated in Miscellaneous at 21% of assets, up from 17% a quarter earlier, followed by Technology and Financials.

  • Sterling Capital Management's largest Q2 2026 buy was Coca-Cola Europacific Partners: 217,119 shares worth $21.7M.
  • Sterling Capital Management added most to Philip Morris in Q2 2026, an estimated $43.1M increase.
  • Sterling Capital Management's biggest Q2 2026 reduction was Marvell Technology, cutting an estimated $47.2M.
  • Sterling Capital Management fully exited Coterra Energy in Q2 2026, selling an estimated $34.4M.
  • Sterling Capital Management's ten largest holdings make up 24% of its $5.9B portfolio in Q2 2026.
  • Sterling Capital Management opened 250 new positions and closed 176 in Q2 2026.
  • Sterling Capital Management's portfolio value rose 12% quarter-over-quarter to $5.9B.

Based on Sterling Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.